[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 846
Citations 0
January 2013

New Appointments to the Editorial Board

JAMA Neurol. 2013;70(1):18. doi:10.1001/jamaneurol.2013.693

With this issue of JAMA Neurology, we welcome Merit E. Cudkowicz, MD, MSc, Randolph S. Marshall, MD, MS, and Benjamin M. Greenberg, MD, to our Editorial Board. We know they will provide the necessary knowledge and scholarship to allow JAMA Neurology to continue to develop and excel. At the same time, we wish to express our profound thanks to James I. Ausman, MD, PhD, Audrey S. Penn, MD, and E. Steve Roach, MD, for serving on the board.

Drs Ausman, Penn, and Roach have served on the Editorial Board since 1997 and their contributions to the development of the journal have been truly significant. We are most grateful to them for their continued efforts on our behalf for the past 15 years. Dr Roach has been selected as the new editor of Pediatric Neurology and we congratulate him and the journal. He will bring outstanding scholarship to this editorship and we wish him great success.

Dr Cudkowicz is the Julieanne Dorn Professor of Neurology at Harvard Medical School and chief of the Neurology Service at the Massachusetts General Hospital, Boston. She received the Sheila Essey ALS Award of the American Academy of Neurology in 2009. She is currently a funded principal investigator of the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke for a “Clinical Trial of Ceftriaxone in Patients With ALS” and for a study on “Coenzyme Q10 in Huntington's Disease.” Dr Cudkowicz's research and clinical activities are dedicated to the study and treatment of patients with neurodegenerative disorders. Her research focus has been on developing novel treatments for amyotrophic lateral sclerosis and Huntington disease. Dr Cudkowicz brings to our Editorial Board a vast experience in clinical and basic neurological research, a distinguished record of scientific publications, and national and international lectureships. Dr Cudkowicz will provide JAMA Neurology with an impressive record and experience in neuromuscular and neurodegenerative diseases that will be invaluable in considering papers for publication and establishing our future editorial plans. We welcome Dr Cudkowicz warmly as a member of the JAMA Neurology Editorial Board.

Merit E. Cudkowicz, MD, MSc

Dr Marshall is professor of neurology at the Neurological Institute of Columbia University Medical Center in New York, where he is chief of the Stroke Division. He is a funded investigator of the NIH/National Institute of Neurological Disorders and Stroke studying “Blood Flow and Cognition.” He has published more than 70 original peer reviewed research articles in addition to invited chapters and reviews. He has been invited to give the C. Miller Fisher Lecture at the Massachusetts General Hospital in 2013. Dr Marshall brings great scholarship and publishing experience to the field of cerebrovascular disease and stroke syndromes and his joining our Editorial Board will provide us with additional significant depth and knowledge. Dr Marshall is a distinguished clinician, teacher, and investigator and we welcome him enthusiastically as a new member of the JAMA Neurology Editorial Board.

Randolph S. Marshall, MD, MS

Dr Greenberg, director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program and a Cain Denius Scholar in Mobility Disorders in the departments of neurology and neurotherapeutics and pediatrics at the University of Texas Southwestern Medical Center at Dallas, will become a member of our Editorial Board and section editor of Viewpoints beginning with this issue, the initial publication of JAMA Neurology. Dr Greenberg received his neurology training at the Johns Hopkins Hospital and postdoctoral fellowship training at the Johns Hopkins School of Public Health. He is coinvestigator on 2 NIH grants funded to study genetic and environmental risk factors for pediatric multiple sclerosis and neuromyelitis optica. He has published more than 30 articles emphasizing the clinical features, immunology, and clinical trials for new therapies for demyelinating diseases.

Viewpoints is a new initiative for JAMA Neurology and will provide our readers with perspectives on emerging issues in clinical practice, neuroeconomics, neuroethics, neuropolitics, neuroethology, NIH research grant funding opportunities and perspectives, clinical trial results, neurology residency and fellowship news and attitudes, and other cutting edge controversies and issues of importance to the greater neurological community. Dr Greenberg has a real interest and expressed insights into all of these matters and Viewpoints under his guidance will become, we believe, a lively and stimulating forum. Stay tuned!

Benjamin M. Greenberg, MD